Review



rabbit polyclonal rad51  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc rabbit polyclonal rad51
    Rabbit Polyclonal Rad51, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+rad51/pm41935081-316-11-14
    Average 86 stars, based on 1 article reviews
    rabbit polyclonal rad51 - by Bioz Stars, 2026-09
    86/100 stars

    Images

    Related Articles

    other:

    Article Title: Ivabradine induces RAD51 degradation, potentiating PARP inhibitor efficacy in non-germline BRCA pathogenic variant triple-negative breast cancer.
    Article Snippet: The following primary antibodies were used: anti-RAD51 (1:1,000; #8875, Cell Signaling Technology), anti-BRCA1 (1:1,000; #9010, Cell Signaling Technology), anti-BRCA2 (1:2,000; #10741, Cell Signaling Technology), anti-HCN2 (APC-030; Alomone Labs), anti-HCN3 (APC-057; Alomone Labs), anti-GFP (1:5000; 632380; Clontech), anti-HSP90 (1:5000; #4878, Cell Signaling Technology), anti-GAPDH (1:20,000; sc-47724, Santa Cruz Biotechnology), anti-phos-ATM (Ser1981) (1:1000; #5883, Cell Signaling Technology), anti-γH2AX (Ser139) (1:1000; #9718, Cell Signaling Technology), anticleaved caspase 3 (1:1,000; #9664, Cell Signaling Technology), anti-FBXO24 (1:,2000; PA5-97737, ThermoFisher Scientific), anti-AIF (1:1,000; #4642, Cell Signaling Technology); anti-β-tubulin (1:10,000; #2146, Cell Signaling Technology) anti-MYC tag (1:4,000; #2276, Cell Signaling Technology), anti-ubiquitin (1:5000; sc-166553, Santa Cruz Biotechnology), and anti-K48-linked polyubiquitin (1:2000; #4289, Cell Signaling Technology).

    Article Title: Synergistic enhancement of PARP inhibition via small molecule UNI66-mediated suppression of BRD4-dependent transcription of RAD51 and CtIP
    Article Snippet: The following antibodies were purchased from the specified suppliers: anti-CtIP (9201S) and anti-RAD51 (8875) were obtained from Cell Signaling Technology.

    Article Title: Ivabradine induces RAD51 degradation, potentiating PARP inhibitor efficacy in non-germline BRCA pathogenic variant triple-negative breast cancer
    Article Snippet: The following primary antibodies were used: anti-RAD51 (1:1,000; #8875, Cell Signaling Technology), anti-BRCA1 (1:1,000; #9010, Cell Signaling Technology), anti-BRCA2 (1:2,000; #10741, Cell Signaling Technology), anti-HCN2 (APC-030; Alomone Labs), anti-HCN3 (APC-057; Alomone Labs), anti-GFP (1:5000; 632380; Clontech), anti-HSP90 (1:5000; #4878, Cell Signaling Technology), anti-GAPDH (1:20,000; sc-47724, Santa Cruz Biotechnology), anti-phos-ATM (Ser1981) (1:1000; #5883, Cell Signaling Technology), anti-γH2AX (Ser139) (1:1000; #9718, Cell Signaling Technology), anti-cleaved caspase 3 (1:1,000; #9664, Cell Signaling Technology), anti-FBXO24 (1:,2000; PA5-97737, ThermoFisher Scientific), anti-AIF (1:1,000; #4642, Cell Signaling Technology); anti-β-tubulin (1:10,000; #2146, Cell Signaling Technology) anti-MYC tag (1:4,000; #2276, Cell Signaling Technology), anti-ubiquitin (1:5000; sc-166553, Santa Cruz Biotechnology), and anti-K48-linked polyubiquitin (1:2000; #4289, Cell Signaling Technology).

    Immunostaining:

    Article Title: MRE11 deacetylation by SIRT2 promotes DNA binding to facilitate DNA end resection and ATM-dependent signaling
    Article Snippet: .. Immunostaining was performed using anti-MRE11 (GeneTex, GTX70212), anti-RPA70 (MilliporeSigma, 2267), anti-RAD51 (Cell Signaling Technology, 14223), and anti-γH2AX (MilliporeSigma, 05-636) antibodies, followed by Alexa Fluor 488 or 555 secondary antibodies (Invitrogen, Thermo Fisher Scientific, A11034 and A21424). .. DNA was visualized with DAPI (Southern Biotech, 0100-20).

    Article Title: MRE11 deacetylation by SIRT2 promotes DNA binding to facilitate DNA end resection and ATM-dependent signaling
    Article Snippet: .. Immunostaining was performed using anti-MRE11 (GeneTex, GTX70212), anti- RPA70 (Sigma, 2267), anti-RAD51 (Cell Signaling #14223) and anti-gH2AX (Millipore # 05- 636) antibodies, followed by Alexa Fluor 488 or 555 secondary antibodies (Invitrogen # A11034 and # A21424). .. DNA was visualized with DAPI (Southern Biotech # 0100-20).

    Incubation:

    Article Title: Epacadostat and Olaparib Synergistically Inhibit the Growth of BRCA-Proficient Triple-Negative Breast Cancer by Suppressing the Expression of BRCA1 and RAD51.
    Article Snippet: Total proteins were extracted from MDA-MB-468 cells and MDA-MB-468 tumor xenografts using RIPA cell lysis buffer (Beyotime, Shanghai, China) supplemented with a protease and phosphatase inhibitor cocktail. .. The membranes were blocked with 5% (w/v) non-fat dry milk and then incubated with primary antibodies, including anti-BRCA1 (1:1000), anti-RAD51 (1:1000), and anti-β-Tubulin (1:5000) from Cell Signaling Technology (Beverly, MA). .. After centrifugation, the supernatant was carefully removed, and protein concentration was determined using the BCA Protein Assay Kit (Thermo Scientific, Waltham, MA, USA).

    Article Title: Epacadostat and Olaparib Synergistically Inhibit the Growth of BRCA-Proficient Triple-Negative Breast Cancer by Suppressing the Expression of BRCA1 and RAD51
    Article Snippet: Briefly, proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and then electrotransferred onto a polyvinylidene difluoride (PVDF) membrane (Millipore, Billerica, MA, USA). .. The membranes were blocked with 5% ( w / v ) non-fat dry milk and then incubated with primary antibodies, including anti-BRCA1 (1:1000), anti-RAD51 (1:1000), and anti-β-Tubulin (1:5000) from Cell Signaling Technology (Beverly, MA). ..



    Similar Products

    94
    MedChemExpress rad51
    Rad51, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+rad51/Chk2+Antibody/pm41904944-245-44-43
    Average 94 stars, based on 1 article reviews
    rad51 - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    94
    Proteintech reca 1
    Prevention of neuroma formation by a spatially confined conduit filled with GelMA MAVP MPS. ( A ) Illustration of 3D-printed GelMA MPs loaded with MAVP and the proposed mechanism of action within the neural conduit. ( B ) Representative images and ( C ) quantitative scores of autotomy behavior over 12 weeks (n = 6). ( D ) Representative gait footprints at 12 weeks post-surgery. ( E ) Quantification of left hindlimb stance duration (n = 6) and ( F ) maximum contact area (n = 6). ( G ) IF staining of p-VEGFR2 activation and ( H ) IF staining of neovascularization marker <t>RECA-1.</t> (I) Quantification of p-VEGFR2-positive area percentage (n = 6). and ( J ) quantification of RECA-1-positive area percentage (n = 6). ( K ) Regenerated nerve length measurements (n = 6). Mean values are shown and error bars represent ± s.d., as analyzed by one-way ANOVA followed by the Tukey-Kramer test in ( C , E , F , I , J and K ). Biological replicates were used for all experiments. ns, p > 0.05, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.
    Reca 1, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+rad51/RAD51+Fusion+Protein/pmc12972984-356-25-23
    Average 94 stars, based on 1 article reviews
    reca 1 - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    86
    Abmart Inc rabbit monoclonal anti rad51 antibody
    Prevention of neuroma formation by a spatially confined conduit filled with GelMA MAVP MPS. ( A ) Illustration of 3D-printed GelMA MPs loaded with MAVP and the proposed mechanism of action within the neural conduit. ( B ) Representative images and ( C ) quantitative scores of autotomy behavior over 12 weeks (n = 6). ( D ) Representative gait footprints at 12 weeks post-surgery. ( E ) Quantification of left hindlimb stance duration (n = 6) and ( F ) maximum contact area (n = 6). ( G ) IF staining of p-VEGFR2 activation and ( H ) IF staining of neovascularization marker <t>RECA-1.</t> (I) Quantification of p-VEGFR2-positive area percentage (n = 6). and ( J ) quantification of RECA-1-positive area percentage (n = 6). ( K ) Regenerated nerve length measurements (n = 6). Mean values are shown and error bars represent ± s.d., as analyzed by one-way ANOVA followed by the Tukey-Kramer test in ( C , E , F , I , J and K ). Biological replicates were used for all experiments. ns, p > 0.05, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.
    Rabbit Monoclonal Anti Rad51 Antibody, supplied by Abmart Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+rad51/anti+monoclonal+rabbit+rad51/pm42273915-154-37-41
    Average 86 stars, based on 1 article reviews
    rabbit monoclonal anti rad51 antibody - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc rabbit polyclonal rad51
    Prevention of neuroma formation by a spatially confined conduit filled with GelMA MAVP MPS. ( A ) Illustration of 3D-printed GelMA MPs loaded with MAVP and the proposed mechanism of action within the neural conduit. ( B ) Representative images and ( C ) quantitative scores of autotomy behavior over 12 weeks (n = 6). ( D ) Representative gait footprints at 12 weeks post-surgery. ( E ) Quantification of left hindlimb stance duration (n = 6) and ( F ) maximum contact area (n = 6). ( G ) IF staining of p-VEGFR2 activation and ( H ) IF staining of neovascularization marker <t>RECA-1.</t> (I) Quantification of p-VEGFR2-positive area percentage (n = 6). and ( J ) quantification of RECA-1-positive area percentage (n = 6). ( K ) Regenerated nerve length measurements (n = 6). Mean values are shown and error bars represent ± s.d., as analyzed by one-way ANOVA followed by the Tukey-Kramer test in ( C , E , F , I , J and K ). Biological replicates were used for all experiments. ns, p > 0.05, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.
    Rabbit Polyclonal Rad51, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+rad51/pm41935081-316-11-14
    Average 86 stars, based on 1 article reviews
    rabbit polyclonal rad51 - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc rad51 d4b10 rabbit mab
    Prevention of neuroma formation by a spatially confined conduit filled with GelMA MAVP MPS. ( A ) Illustration of 3D-printed GelMA MPs loaded with MAVP and the proposed mechanism of action within the neural conduit. ( B ) Representative images and ( C ) quantitative scores of autotomy behavior over 12 weeks (n = 6). ( D ) Representative gait footprints at 12 weeks post-surgery. ( E ) Quantification of left hindlimb stance duration (n = 6) and ( F ) maximum contact area (n = 6). ( G ) IF staining of p-VEGFR2 activation and ( H ) IF staining of neovascularization marker <t>RECA-1.</t> (I) Quantification of p-VEGFR2-positive area percentage (n = 6). and ( J ) quantification of RECA-1-positive area percentage (n = 6). ( K ) Regenerated nerve length measurements (n = 6). Mean values are shown and error bars represent ± s.d., as analyzed by one-way ANOVA followed by the Tukey-Kramer test in ( C , E , F , I , J and K ). Biological replicates were used for all experiments. ns, p > 0.05, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.
    Rad51 D4b10 Rabbit Mab, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+rad51/Rad51+Rabbit+mAb/pm41900138-175-4-31
    Average 96 stars, based on 1 article reviews
    rad51 d4b10 rabbit mab - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc anti rad51
    Prevention of neuroma formation by a spatially confined conduit filled with GelMA MAVP MPS. ( A ) Illustration of 3D-printed GelMA MPs loaded with MAVP and the proposed mechanism of action within the neural conduit. ( B ) Representative images and ( C ) quantitative scores of autotomy behavior over 12 weeks (n = 6). ( D ) Representative gait footprints at 12 weeks post-surgery. ( E ) Quantification of left hindlimb stance duration (n = 6) and ( F ) maximum contact area (n = 6). ( G ) IF staining of p-VEGFR2 activation and ( H ) IF staining of neovascularization marker <t>RECA-1.</t> (I) Quantification of p-VEGFR2-positive area percentage (n = 6). and ( J ) quantification of RECA-1-positive area percentage (n = 6). ( K ) Regenerated nerve length measurements (n = 6). Mean values are shown and error bars represent ± s.d., as analyzed by one-way ANOVA followed by the Tukey-Kramer test in ( C , E , F , I , J and K ). Biological replicates were used for all experiments. ns, p > 0.05, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.
    Anti Rad51, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+rad51/pm41900138-252-19-25
    Average 86 stars, based on 1 article reviews
    anti rad51 - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology rad51
    Prevention of neuroma formation by a spatially confined conduit filled with GelMA MAVP MPS. ( A ) Illustration of 3D-printed GelMA MPs loaded with MAVP and the proposed mechanism of action within the neural conduit. ( B ) Representative images and ( C ) quantitative scores of autotomy behavior over 12 weeks (n = 6). ( D ) Representative gait footprints at 12 weeks post-surgery. ( E ) Quantification of left hindlimb stance duration (n = 6) and ( F ) maximum contact area (n = 6). ( G ) IF staining of p-VEGFR2 activation and ( H ) IF staining of neovascularization marker <t>RECA-1.</t> (I) Quantification of p-VEGFR2-positive area percentage (n = 6). and ( J ) quantification of RECA-1-positive area percentage (n = 6). ( K ) Regenerated nerve length measurements (n = 6). Mean values are shown and error bars represent ± s.d., as analyzed by one-way ANOVA followed by the Tukey-Kramer test in ( C , E , F , I , J and K ). Biological replicates were used for all experiments. ns, p > 0.05, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.
    Rad51, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+rad51/Rad51+Antibody/pm41896195-220-10-7
    Average 96 stars, based on 1 article reviews
    rad51 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology flag dykddddk
    Prevention of neuroma formation by a spatially confined conduit filled with GelMA MAVP MPS. ( A ) Illustration of 3D-printed GelMA MPs loaded with MAVP and the proposed mechanism of action within the neural conduit. ( B ) Representative images and ( C ) quantitative scores of autotomy behavior over 12 weeks (n = 6). ( D ) Representative gait footprints at 12 weeks post-surgery. ( E ) Quantification of left hindlimb stance duration (n = 6) and ( F ) maximum contact area (n = 6). ( G ) IF staining of p-VEGFR2 activation and ( H ) IF staining of neovascularization marker <t>RECA-1.</t> (I) Quantification of p-VEGFR2-positive area percentage (n = 6). and ( J ) quantification of RECA-1-positive area percentage (n = 6). ( K ) Regenerated nerve length measurements (n = 6). Mean values are shown and error bars represent ± s.d., as analyzed by one-way ANOVA followed by the Tukey-Kramer test in ( C , E , F , I , J and K ). Biological replicates were used for all experiments. ns, p > 0.05, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.
    Flag Dykddddk, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+rad51/Rad51+Antibody/bio_rxiv__64898__2026__03__24__714005-211-42-43
    Average 96 stars, based on 1 article reviews
    flag dykddddk - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    95
    Novus Biologicals mouse anti rad51
    Prevention of neuroma formation by a spatially confined conduit filled with GelMA MAVP MPS. ( A ) Illustration of 3D-printed GelMA MPs loaded with MAVP and the proposed mechanism of action within the neural conduit. ( B ) Representative images and ( C ) quantitative scores of autotomy behavior over 12 weeks (n = 6). ( D ) Representative gait footprints at 12 weeks post-surgery. ( E ) Quantification of left hindlimb stance duration (n = 6) and ( F ) maximum contact area (n = 6). ( G ) IF staining of p-VEGFR2 activation and ( H ) IF staining of neovascularization marker <t>RECA-1.</t> (I) Quantification of p-VEGFR2-positive area percentage (n = 6). and ( J ) quantification of RECA-1-positive area percentage (n = 6). ( K ) Regenerated nerve length measurements (n = 6). Mean values are shown and error bars represent ± s.d., as analyzed by one-way ANOVA followed by the Tukey-Kramer test in ( C , E , F , I , J and K ). Biological replicates were used for all experiments. ns, p > 0.05, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.
    Mouse Anti Rad51, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+rad51/Rad51+Antibody+(14B4)/bio_rxiv__64898__2026__03__18__712809-128-4-7
    Average 95 stars, based on 1 article reviews
    mouse anti rad51 - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    Image Search Results


    Prevention of neuroma formation by a spatially confined conduit filled with GelMA MAVP MPS. ( A ) Illustration of 3D-printed GelMA MPs loaded with MAVP and the proposed mechanism of action within the neural conduit. ( B ) Representative images and ( C ) quantitative scores of autotomy behavior over 12 weeks (n = 6). ( D ) Representative gait footprints at 12 weeks post-surgery. ( E ) Quantification of left hindlimb stance duration (n = 6) and ( F ) maximum contact area (n = 6). ( G ) IF staining of p-VEGFR2 activation and ( H ) IF staining of neovascularization marker RECA-1. (I) Quantification of p-VEGFR2-positive area percentage (n = 6). and ( J ) quantification of RECA-1-positive area percentage (n = 6). ( K ) Regenerated nerve length measurements (n = 6). Mean values are shown and error bars represent ± s.d., as analyzed by one-way ANOVA followed by the Tukey-Kramer test in ( C , E , F , I , J and K ). Biological replicates were used for all experiments. ns, p > 0.05, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.

    Journal: Bioactive Materials

    Article Title: Targeting VEGFR2 inhibition within a spatially-confined conduit promotes nerve self-resolution and alleviates mechanical allodynia

    doi: 10.1016/j.bioactmat.2026.03.009

    Figure Lengend Snippet: Prevention of neuroma formation by a spatially confined conduit filled with GelMA MAVP MPS. ( A ) Illustration of 3D-printed GelMA MPs loaded with MAVP and the proposed mechanism of action within the neural conduit. ( B ) Representative images and ( C ) quantitative scores of autotomy behavior over 12 weeks (n = 6). ( D ) Representative gait footprints at 12 weeks post-surgery. ( E ) Quantification of left hindlimb stance duration (n = 6) and ( F ) maximum contact area (n = 6). ( G ) IF staining of p-VEGFR2 activation and ( H ) IF staining of neovascularization marker RECA-1. (I) Quantification of p-VEGFR2-positive area percentage (n = 6). and ( J ) quantification of RECA-1-positive area percentage (n = 6). ( K ) Regenerated nerve length measurements (n = 6). Mean values are shown and error bars represent ± s.d., as analyzed by one-way ANOVA followed by the Tukey-Kramer test in ( C , E , F , I , J and K ). Biological replicates were used for all experiments. ns, p > 0.05, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.

    Article Snippet: The following primary antibodies were used for the subsequent steps: anti-Yap (mouse, 1:200, Santa sc-376830); anti-p-VEGFR2 (rabbit, 1:100 Invitrogen, PA5-105765); α-SMA (rabbit, 1:200, Proteintech 14395-1-AP); Reca-1 (mouse, 1:200, Santa sc-52665); anti-CD31 (mouse, 1:200, Santa sc-13537); anti-Ki67 (rabbit, 1:150, Cell Signaling 9129S); anti-NF-200 (mouse, 1:200, Sigma, SAB4200747); anti-MBP (rabbit, 1:200, Abcam ab218011); anti-F4/80 (mouse, 1:200, Santa sc-377009); Iba-1 (rabbit, 1:150, Abcam ab178846); anti-CGRP (rabbit, 1:400, Abcam ab283568); anti-TRPA1 (mouse, 1:200, Santa sc-376495); anti-CD86 (rabbit, 1:200, Proteintech 30691-1-AP); CD206 (rabbit, 1:200, Proteintech 18704-1-AP).

    Techniques: Staining, Activation Assay, Marker